E-Articles
#1 in Business Subscribe Email Print

You are here: Home > Health and Fitness > Obesity > Obesity: A Disease With Deadly Complication

Tags

  • challenges
  • obesity
  • drugs
  • developing combination
  • developing combination
  • biological product

  • Links

  • Flat Screen Monitors: A Technological Wonder
  • Homeowner Personal Loans Are Conventional Method Of Borrowing
  • The Advantages Of The Wireless Video Security Camera
  • E-Articles - Obesity: A Disease With Deadly Complication

    Despite a better perception regarding causes of obesity, the number
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    of obese and overweight people is rising at an alarming rate. Acco
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    ding to statistics presented at the 14th European Congress on Obesi
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    ty, more than 300 million people worldwide are affected by obesity.
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    Studies evaluate that obesity rates in Europe have risen 15 percent
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    in the past ten years, while in Japan it has doubled since 1982.
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc


    The big concern among specialists is the astounding numbe
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    of obese and overweight children. In the US for instance, the per
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    centage of obese young population has tripled in the past 25 years.
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ


    Obesity is no more an aestetic problem. In some West Eur
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    pe countries, up to 8 percent of total healthcare budget is related
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    to obesity and its complications. In our days, the obese condition
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    is tightly connected to a number of severe diseases such as diabete
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    s, atherosclerosis and other significant health problems that are c
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    nsiderate causes of death.

    The actual finding that exces
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    s weight is going epidemic leads to the conclusion that obesity mus
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    be recognized and treated as a disease with fatal complications. M
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    st of the prevention efforts must target the young population becau
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    se obese condition in children is close associated to certain high
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    isks of developing heart disease, stroke and diabetes in later life


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.e-article.org.ua/article/261851/e-article-Obesity-A-Disease-With-Deadly-Complication.html">Obesity: A Disease With Deadly Complication</a>

    BB link (for phorums):
    [url=http://www.e-article.org.ua/article/261851/e-article-Obesity-A-Disease-With-Deadly-Complication.html]Obesity: A Disease With Deadly Complication[/url]

    Related Articles:

    Your Swimming Pool is an Energy Hog - Learn How to Save Hundreds on Your Electric Bill

    How to Learn Reiki and Become a Reiki Master

    Declining Sexual Performance, Testosterone Effects And A New Biofeedback Technology

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com